Biogen Inc. buy UBS Group AG
Start price
24.07.23
/
50%
€249.60
Target price
24.07.24
€302.51
Performance (%)
-16.51%
End price
25.07.24
€208.40
Summary
This prediction ended on 25.07.24 with a price of €208.40. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.51%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -4.122% | -4.122% | 45.281% |
| iShares Core DAX® | 2.554% | 0.562% | 14.142% |
| iShares Nasdaq 100 | 2.742% | -0.599% | 30.370% |
| iShares Nikkei 225® | 6.584% | 4.336% | 49.372% |
| iShares S&P 500 | 1.930% | -0.507% | 24.257% |
Comments by UBS_Group_AG for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at UBS Group AG from $346.00 to $335.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten